Ledger.Open graph →
SEC Form D · filed February 10, 2025

Allay Therapeutics, Inc

Offering
$60.0M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN JOSE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Michael A. Carusi · San Jose, CADirectorNicole A. Vitullo · San Jose, CADirectorMark A. Deem · San Jose, CADirectorAdam A. Gridley · San Jose, CAExec · DirectorPaul A. Mccreadie · San Jose, CADirectorLeighton A. Read · San Jose, CADirectorNicole A. Vitullo · San Jose, CADirectorLeighton A. Read · San Jose, CADirectorPaul A. Mccreadie · San Jose, CADirectorMark A. Deem · San Jose, CADirectorAdam A. Gridley · San Jose, CAExec · DirectorMichael A. Carusi · San Jose, CADirectorTiffany A. Le · San Jose, CADirectorJ.C. A. Lopez · San Jose, CADirectorAnselm A. Tan · San Jose, CADirectorKristen A. Howells · San Jose, CAExecVasant K. Natarajan · Palo Alto, CADirectorAlexander Lewin · CAMBRIDGE, MADirectorF. H. Mandel · Chagrin Falls, OHDirectorRyan D. Lepene · Chagrin Falls, OHExec · DirectorNicholas Van Eck · Jersey City, NJDirectorAndrew D. Evans · Jersey City, NJDirectorTiffany A. Le · San Jose, CADirectorJ.C. A. Lopez · San Jose, CADirectorAnselm A. Tan · San Jose, CADirectorKristen A. Howells · San Jose, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗